Comparing antibody-negative ALE and IDH-WT glioma patients, the percentage of CD8+ Tc in PB was lower and the fraction of Tc in CSF higher in antibody-negative ALE (Fig. 2B, E, N). This evidence concerns the gene CD8A and central nervous system cancer.